Researchers have revealed that a stroke could alter an individual’s microbiome even up to 1 month after it occurs; this has emphasized the importance of incorporating gut health in patient recovery and treatment.
A recent study has demonstrated that overweight individuals may be more likely to survive a stroke than people of normal weight.
In this review from Biomarkers in Medicine, researchers demonstrate that PARK7 and NDKA could present more clinical important information as biomarkers for management of stroke disease.
Couldn’t attend the International Stroke Conference (6–8 February 2019, Honolulu, HI, USA)? Find out more about the key headlines here.
An experimental drug being developed for the treatment of stroke may also prevent Alzheimer’s by preventing the build-up of toxic proteins.
This week we look at gammaCore™ for cluster headache, warnings of stroke risk with a multiple sclerosis drug and a gene therapy for spinal muscular atrophy.
Couldn’t attend the 143rd Annual Meeting of the American Neurological Association? Discover more about the key highlights here.
Couldn’t attend the 11th World Stroke Congress (17–20 October 2018, Montreal, Canada)? Find out more about the key headlines here.
Researchers have revealed that taking a simple test within a week of a stroke may help to predict the long-term prognosis of a patient; this information could be beneficial for patients when making treatment and long-term care decisions.
This week’s industry news round-up reveals the latest updates around spinal muscular atrophy, Parkinson’s disease and acute stroke.